Home Applications 212306 Application 212306
Type NDA
Sponsor KARYOPHARM THERAPS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 XPOVIO SELINEXOR TABLET;ORAL 20MG Yes Yes 002 XPOVIO SELINEXOR TABLET;ORAL 40MG Yes No 003 XPOVIO SELINEXOR TABLET;ORAL 50MG Yes No 004 XPOVIO SELINEXOR TABLET;ORAL 60MG Yes No 005 XPOVIO SELINEXOR TABLET;ORAL 10MG Yes No 006 XPOVIO SELINEXOR TABLET;ORAL 80MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N212306-001 XPOVIO SELINEXOR 20MG TABLET / ORAL RLD 2019-07-03 N212306-002 XPOVIO SELINEXOR 40MG TABLET / ORAL RLD 2021-04-15 N212306-003 XPOVIO SELINEXOR 50MG TABLET / ORAL RLD 2021-04-15 N212306-004 XPOVIO SELINEXOR 60MG TABLET / ORAL RLD, RS 2021-04-15 N212306-005 XPOVIO SELINEXOR 10MG TABLET / ORAL RLD 2025-03-10 N212306-006 XPOVIO SELINEXOR 80MG TABLET / ORAL RLD 2025-10-20
Orange Book patents# Current patent rows page 1 of 2 · 115 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N212306-001 10544108 2032-07-26 U-2584 2020-02-24 N212306-001 10544108 2032-07-26 U-3018 2020-02-24 N212306-001 11034660 2032-07-26 U-2584 2021-07-14 N212306-001 11034660 2032-07-26 U-3018 2021-07-14 N212306-001 11787771 2032-07-26 U-2584 2023-11-15 N212306-001 11787771 2032-07-26 U-2855 2023-11-15 N212306-001 11787771 2032-07-26 U-3018 2023-11-15 N212306-001 12291508 2032-07-26 U-2584 2025-06-04 N212306-001 12291508 2032-07-26 U-3018 2025-06-04 N212306-001 9079865 2032-07-26 U-2584 2019-07-31 N212306-001 9079865 2032-07-26 U-3018 2019-07-31 N212306-001 9714226 2032-07-26 Drug substance, Drug product 2019-07-31 N212306-001 8999996 2033-07-03 Drug substance, Drug product 2019-07-31 N212306-001 10519139 2035-08-14 U-2584 Drug substance, Drug product 2020-01-27 N212306-001 10519139 2035-08-14 U-3018 Drug substance, Drug product 2020-01-27 N212306-001 11746102 2035-08-14 U-2584 2023-10-04 N212306-001 11746102 2035-08-14 U-3018 2023-10-04 N212306-001 11753401 2035-08-14 U-2584 Drug product 2023-10-11 N212306-001 11753401 2035-08-14 U-3018 Drug product 2023-10-11 N212306-001 11807629 2035-08-14 Drug substance, Drug product 2023-12-06 N212306-002 10544108 2032-07-26 U-2584 2021-07-19 N212306-002 10544108 2032-07-26 U-3018 2021-07-19 N212306-002 11034660 2032-07-26 U-2584 2021-07-14 N212306-002 11034660 2032-07-26 U-3018 2021-07-14 N212306-002 11787771 2032-07-26 U-2584 2023-11-15 N212306-002 11787771 2032-07-26 U-3018 2023-11-15 N212306-002 12291508 2032-07-26 U-2584 2025-06-04 N212306-002 12291508 2032-07-26 U-3018 2025-06-04 N212306-002 9079865 2032-07-26 U-2584 2021-07-19 N212306-002 9079865 2032-07-26 U-3018 2021-07-19 N212306-002 9714226 2032-07-26 Drug substance, Drug product 2021-07-19 N212306-002 8999996 2033-07-03 Drug substance, Drug product 2021-07-19 N212306-002 10519139 2035-08-14 U-2584 Drug substance, Drug product 2021-07-19 N212306-002 10519139 2035-08-14 U-3018 Drug substance, Drug product 2021-07-19 N212306-002 11746102 2035-08-14 U-2584 2023-10-04 N212306-002 11746102 2035-08-14 U-3018 2023-10-04 N212306-002 11753401 2035-08-14 U-2584 Drug product 2023-10-11 N212306-002 11753401 2035-08-14 U-3018 Drug product 2023-10-11 N212306-002 11807629 2035-08-14 Drug substance, Drug product 2023-12-06 N212306-003 10544108 2032-07-26 U-2584 2021-07-19 N212306-003 10544108 2032-07-26 U-3018 2021-07-19 N212306-003 11034660 2032-07-26 U-2584 2021-07-14 N212306-003 11034660 2032-07-26 U-3018 2021-07-14 N212306-003 11787771 2032-07-26 U-2584 2023-11-15 N212306-003 11787771 2032-07-26 U-3018 2023-11-15 N212306-003 12291508 2032-07-26 U-2584 2025-06-04 N212306-003 12291508 2032-07-26 U-3018 2025-06-04 N212306-003 9079865 2032-07-26 U-2584 2021-07-19 N212306-003 9079865 2032-07-26 U-3018 2021-07-19 N212306-003 9714226 2032-07-26 Drug substance, Drug product 2021-07-19 N212306-003 8999996 2033-07-03 Drug substance, Drug product 2021-07-19 N212306-003 10519139 2035-08-14 U-2584 Drug substance, Drug product 2021-07-19 N212306-003 10519139 2035-08-14 U-3018 Drug substance, Drug product 2021-07-19 N212306-003 11746102 2035-08-14 U-2584 2023-10-04 N212306-003 11746102 2035-08-14 U-3018 2023-10-04 N212306-003 11753401 2035-08-14 U-2584 Drug product 2023-10-11 N212306-003 11753401 2035-08-14 U-3018 Drug product 2023-10-11 N212306-003 11807629 2035-08-14 Drug substance, Drug product 2023-12-06 N212306-004 10544108 2032-07-26 U-2584 2021-07-19 N212306-004 10544108 2032-07-26 U-3018 2021-07-19 N212306-004 11034660 2032-07-26 U-2584 2021-07-14 N212306-004 11034660 2032-07-26 U-3018 2021-07-14 N212306-004 11787771 2032-07-26 U-2584 2023-11-15 N212306-004 11787771 2032-07-26 U-3018 2023-11-15 N212306-004 12291508 2032-07-26 U-2584 2025-06-04 N212306-004 12291508 2032-07-26 U-3018 2025-06-04 N212306-004 9079865 2032-07-26 U-2584 2021-07-19 N212306-004 9079865 2032-07-26 U-3018 2021-07-19 N212306-004 9714226 2032-07-26 Drug substance, Drug product 2021-07-19 N212306-004 8999996 2033-07-03 Drug substance, Drug product 2021-07-19 N212306-004 10519139 2035-08-14 U-2584 Drug substance, Drug product 2021-07-19 N212306-004 10519139 2035-08-14 U-3018 Drug substance, Drug product 2021-07-19 N212306-004 11746102 2035-08-14 U-2584 2023-10-04 N212306-004 11746102 2035-08-14 U-3018 2023-10-04 N212306-004 11753401 2035-08-14 U-2584 Drug product 2023-10-11 N212306-004 11753401 2035-08-14 U-3018 Drug product 2023-10-11 N212306-004 11807629 2035-08-14 Drug substance, Drug product 2023-12-06 N212306-005 10544108 2032-07-26 U-2584 2025-04-08 N212306-005 10544108 2032-07-26 U-3018 2025-04-08 N212306-005 11034660 2032-07-26 U-2584 2025-04-08
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 17 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 158 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-005 XPOVIO 10MG TABLET / ORAL RLD 2025-03-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-006 XPOVIO 80MG TABLET / ORAL RLD 2025-10-20 84e616aacf4f…2026-08-18 06:07:40 2026-07 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212306-005 XPOVIO 10MG TABLET / ORAL RLD 2025-03-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N212306-006 XPOVIO 80MG TABLET / ORAL RLD 2025-10-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212306-005 XPOVIO 10MG TABLET / ORAL RLD 2025-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N212306-006 XPOVIO 80MG TABLET / ORAL RLD 2025-10-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212306-005 XPOVIO 10MG TABLET / ORAL RLD 2025-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N212306-006 XPOVIO 80MG TABLET / ORAL RLD 2025-10-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N212306-005 XPOVIO 10MG TABLET / ORAL RLD 2025-03-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N212306-004 XPOVIO 60MG TABLET / ORAL RLD, RS 2021-04-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212306-001 XPOVIO 20MG TABLET / ORAL RLD 2019-07-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212306-002 XPOVIO 40MG TABLET / ORAL RLD 2021-04-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N212306-003 XPOVIO 50MG TABLET / ORAL RLD 2021-04-15 03ed91905a0d…
Observed Orange Book patent history# Patent history page 1 of 71 · 2,801 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N212306-001 10544108 2032-07-26 U-2584 2020-02-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 10544108 2032-07-26 U-3018 2020-02-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11034660 2032-07-26 U-2584 2021-07-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11034660 2032-07-26 U-3018 2021-07-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11787771 2032-07-26 U-2855 2023-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11787771 2032-07-26 U-2584 2023-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11787771 2032-07-26 U-3018 2023-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 12291508 2032-07-26 U-3018 2025-06-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 12291508 2032-07-26 U-2584 2025-06-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 9079865 2032-07-26 U-2584 2019-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 9079865 2032-07-26 U-3018 2019-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 9714226 2032-07-26 Drug substance, Drug product 2019-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 8999996 2033-07-03 Drug substance, Drug product 2019-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 10519139 2035-08-14 U-2584 Drug substance, Drug product 2020-01-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 10519139 2035-08-14 U-3018 Drug substance, Drug product 2020-01-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11746102 2035-08-14 U-2584 2023-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11746102 2035-08-14 U-3018 2023-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11753401 2035-08-14 U-2584 Drug product 2023-10-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11753401 2035-08-14 U-3018 Drug product 2023-10-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-001 11807629 2035-08-14 Drug substance, Drug product 2023-12-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 10544108 2032-07-26 U-3018 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 10544108 2032-07-26 U-2584 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11034660 2032-07-26 U-2584 2021-07-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11034660 2032-07-26 U-3018 2021-07-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11787771 2032-07-26 U-3018 2023-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11787771 2032-07-26 U-2584 2023-11-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 12291508 2032-07-26 U-2584 2025-06-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 12291508 2032-07-26 U-3018 2025-06-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 9079865 2032-07-26 U-2584 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 9079865 2032-07-26 U-3018 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 9714226 2032-07-26 Drug substance, Drug product 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 8999996 2033-07-03 Drug substance, Drug product 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 10519139 2035-08-14 U-2584 Drug substance, Drug product 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 10519139 2035-08-14 U-3018 Drug substance, Drug product 2021-07-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11746102 2035-08-14 U-2584 2023-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11746102 2035-08-14 U-3018 2023-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11753401 2035-08-14 U-2584 Drug product 2023-10-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11753401 2035-08-14 U-3018 Drug product 2023-10-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-002 11807629 2035-08-14 Drug substance, Drug product 2023-12-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N212306-003 10544108 2032-07-26 U-2584 2021-07-19 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 2 of 13 · 512 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 22 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-101 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-102 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-102 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-102 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-102 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-103 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-103 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-103 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-103 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-104 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-104 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-104 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current 72237-104 XPOVIO selinexor Karyopharm Therapeutics Inc. NDA Current